drugset / Trial / NCT03220165
Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is determine in healthy males how MGL-3196 is metabolized using a radio-labeled version of MGL-3196.
Timeline
- Start
- 2017-08-06
- Primary completion
- 2017-09-03
- Completion
- 2017-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resmetirom | Small molecule | 100 mg | Oral |
Indications
No indication recorded.